Mir Mukkaram Ali

USPTO Granted Patents = 27 (Patent Applications = 13)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 3.5

ph-index = 17

Forward Citations = 1,313(Granted Patents)

Company Filing History:

16 out of 27

Bind Therapeutics, Inc.

patents

7 out of 12

Bind Biosciences, Inc.

Years Active: 2012-2018

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10071056 - Cancer cell targeting using nanoparticles (2018-09-11),

2. 9835572 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2017-12-05),

3. 9579386 - Drug loaded polymeric nanoparticles and methods of making and using same (2017-02-28),

4. 9579284 - Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same (2017-02-28),

5. 9393310 - Drug loaded polymeric nanoparticles and methods of making and using same (2016-07-19),

6. 9351933 - Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same (2016-05-31),

7. 9308179 - Long circulating nanoparticles for sustained release of therapeutic agents (2016-04-12),

8. 9295727 - Cancer cell targeting using nanoparticles (2016-03-29),

9. 9295649 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2016-03-29),

10. 9198874 - Long circulating nanoparticles for sustained release of therapeutic agents (2015-12-01),

11. 8912212 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2014-12-16),

12. 8734846 - Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles (2014-05-27),

13. 8623417 - Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same (2014-01-07),

14. 8617608 - Drug loaded polymeric nanoparticles and methods of making and using same (2013-12-31),

15. 8613954 - Drug loaded polymeric nanoparticles and methods of making and using same (2013-12-24),

Title: Mir Mukkaram Ali: Pioneering Innovations in Nanoparticle Technology

Introduction

Mir Mukkaram Ali, based in Woburn, Massachusetts, is an accomplished inventor with an impressive portfolio of 27 patents. His work primarily focuses on cutting-edge innovations in the field of nanotechnology, particularly in developing nanoparticles that have significant implications in cancer therapeutics.

Latest Patents

Among his latest patents, one notable invention is centered around cancer cell targeting using nanoparticles. This invention relates to the development of polymers and macromolecules, which can be utilized in creating nanoparticles with desired properties. The method involves producing libraries of nanoparticles with highly controlled characteristics by mixing various macromolecules in different ratios. Some of these nanoparticles may include drug components, enhancing their therapeutic effectiveness.

Another significant patent involves therapeutic polymeric nanoparticle compositions characterized by high glass transition temperatures or high molecular weight copolymers. This disclosure pertains to pharmaceutical compositions that comprise these specialized polymeric nanoparticles, offering innovative methods for their production.

Career Highlights

Mir has contributed to the biotechnology sector through his work at companies such as Bind Therapeutics, Inc. and Bind Biosciences, Inc. His innovations have played a crucial role in advancing the efficacy of cancer treatments, showcasing his expertise in both engineering and medical applications of nanoparticles.

Collaborations

During his career, Mir Mukkaram Ali has collaborated with several notable professionals, including Stephen E. Zale and Greg Troiano. These collaborations have further facilitated advancements in the development of nanoparticle technologies, creating impactful solutions in cancer therapy.

Conclusion

With a strong focus on innovation, Mir Mukkaram Ali continues to drive forward the boundaries of nanoparticle research. His numerous patents and collaborative efforts underscore his significant contributions to the field, positioning him as a leading figure in the development of advanced therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.